Brain Cancer (Chemotherapy)

FDA Approves Temodar Drug To Treat Cancer

Published in Cancer Weekly, August 23rd, 1999

The U.S. Food and Drug Administration (FDA) said it had approved the Schering-Plough Corp. drug Temodar to treat a form of brain cancer.

The FDA said the drug, known generically as temozolomide, could be used to treat patients with brain tumors known as anaplastic astrocytoma who have relapsed following chemotherapy.

"The approval of temozolomide gives patients another option for treatment of their disease when they do not respond to initial treatment with radiation and chemotherapy," the FDA said in a statement announcing the drug's approval.

Temodar's side effects included headaches, nausea, vomiting, fatigue, and low blood...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1999-08-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry